These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8097419)

  • 1. Diabetes mellitus in cystic fibrosis: genetic and immunological markers.
    Lanng S; Thorsteinsson B; Pociot F; Marshall MO; Madsen HO; Schwartz M; Nerup J; Koch C
    Acta Paediatr; 1993 Feb; 82(2):150-4. PubMed ID: 8097419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus.
    Pociot F; Mølvig J; Wogensen L; Worsaae H; Dalbøge H; Baek L; Nerup J
    Scand J Immunol; 1991 Jan; 33(1):37-49. PubMed ID: 1996407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study.
    Deschamps I; Boitard C; Hors J; Busson M; Marcelli-Barge A; Mogenet A; Robert JJ
    Diabetologia; 1992 Oct; 35(10):951-7. PubMed ID: 1451952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet autoantibodies and insulin dependent diabetes mellitus in cystic fibrosis.
    Nousia-Arvanitakis S; Galli-Tsinopoulou A; Dracoulacos D; Karamouzis M; Demitriadou A
    J Pediatr Endocrinol Metab; 2000 Mar; 13(3):319-24. PubMed ID: 10714759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-cell autoantibodies and diabetes mellitus family history in cystic fibrosis.
    Minicucci L; Cotellessa M; Pittaluga L; Minuto N; d'Annunzio G; Avanzini MA; Lorini R
    J Pediatr Endocrinol Metab; 2005 Aug; 18(8):755-60. PubMed ID: 16200841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.
    Thivolet C; Beaufrére B; Bétuel H; Gebuhrer L; Chatelain P; Durand A; Tourniaire J; François R
    Diabetologia; 1988 Oct; 31(10):741-6. PubMed ID: 3071483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group.
    Sabbah E; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2455-9. PubMed ID: 8675560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet-cell cytoplasmic antibodies in Japanese diabetics.
    Shinjyo T; Hirata Y; Maruyama H; Ishiba S; Matuura N; Fukushima N; Wakisaka A
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():265-9. PubMed ID: 6393434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-type 1 (insulin-dependent) diabetes: common endocrinological course despite immunological and immunogenetic heterogeneity.
    Srikanta S; Ganda OP; Jackson RA; Brink SJ; Fleischnick E; Yunis E; Alper C; Soeldner JS; Eisenbarth GS
    Diabetologia; 1984 Jul; 27 Suppl():146-8. PubMed ID: 6383919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
    Horton V; Stratton I; Bottazzo GF; Shattock M; Mackay I; Zimmet P; Manley S; Holman R; Turner R
    Diabetologia; 1999 May; 42(5):608-16. PubMed ID: 10333055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
    Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
    Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
    Honeyman MC; Harrison LC; Drummond B; Colman PG; Tait BD
    Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients.
    Thivolet C; Beaufrère B; Geburher L; Chatelain P; Orgiazzi J; François R
    Diabetologia; 1991 Mar; 34(3):186-91. PubMed ID: 1884891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies.
    Bärmeier H; McCulloch DK; Neifing JL; Warnock G; Rajotte RV; Palmer JP; Lernmark A
    Diabetologia; 1991 Oct; 34(10):727-33. PubMed ID: 1959705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-GAD65 reactive peripheral blood mononuclear cells in the pathogenesis of cystic fibrosis related diabetes mellitus.
    Stechova K; Kolouskova S; Sumnik Z; Cinek O; Kverka M; Faresjo MK; Chudoba D; Dovolilova E; Pechova M; Vrabelova Z; Böhmova K; Janecek L; Saudek F; Vavrinec J
    Autoimmunity; 2005 Jun; 38(4):319-23. PubMed ID: 16206514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.
    Metcalfe KA; Hitman GA; Fennessy MJ; McCarthy MI; Tuomilehto J; Tuomilehto-Wolf E
    Diabetologia; 1995 Oct; 38(10):1223-9. PubMed ID: 8690176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HLA-antigens and islet cell antibodies in type-1 diabetics of various age groups and their first-degree relatives].
    Spinas GA; Keller U; Neri TM; Matter L; Staffelbach O; Berger W
    Schweiz Med Wochenschr; 1985 Jan; 115(2):48-54. PubMed ID: 3881821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis.
    Couce M; O'Brien TD; Moran A; Roche PC; Butler PC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1267-72. PubMed ID: 8772610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.